Feihe (06186) revenue exceeds 20.7 billion yuan in 2024, performance growth driven by in-depth research in technology.

On March 28th, CHINA FEIHE (06186) released its full-year performance for 2024. The data shows that Feihe achieved a revenue of 20.75 billion yuan in 2024, a year-on-year increase of 6%, and a net profit of 3.65 billion yuan, a year-on-year increase of 11%. According to Frost & Sullivan data, as of 2024, Feihe has been the number one in the Chinese infant formula milk powder market for six consecutive years, and the number one in global infant formula milk powder sales for four consecutive years. Technological innovation has become the core engine for Feihe's high-quality performance development. In 2024, Feihe added 153 authorized patents domestically and internationally, with a total of 659 authorized patents. In January of this year, Feihe released the technology of milk protein fresh extraction, achieving a "lane change overtaking" in dairy product quality, and opening a new era of functional nutrition.